Sort
172,184 grants matching “inflammation”
Studies in the Pathogenesis of Systemic Capillary Leak Syndrome
$742,042Kirk Druey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
University of Washington Center for Aids Research
$742,010King Kennard Holmes · University Of Washington · P30 · FY2014 · AI
DARC, Inflammaging and Alzheimer's Disease
$741,989Xin-Yun Lu · Augusta University · R01 · FY2025 · AG
Development of lung T cell responses in infant respiratory immunity
$741,976Donna L Farber · Columbia University Health Sciences · U01 · FY2021 · AI
Targeting the Cholinergic Pathway in HIV-associated Inflammation and Cognitive Dysfunction
$741,975Rebecca Ashare · University Of Pennsylvania · R01 · FY2020 · DA
A twin study of obesity pathogenesis using fMRI
$741,959Ellen A Schur · University Of Washington · R01 · FY2019 · DK
Micro Analytical Immunochemistry
$741,947Heather Kalish · National Institute Of Biomedical Imaging And Bioengineering · ZIC · FY2021 · EB
Cardiac microstructure and the immune-inflammatory response to SARS-CoV-2
$741,942Susan Cheng · Cedars-Sinai Medical Center · R01 · FY2023 · HL
GBS mediated in utero fetal injury
$741,923Lakshmi Rajagopal · Seattle Children'S Hospital · R01 · FY2016 · AI
Biomimetic nanomaterials for the immunomodulation of the cardiosplenic axis post-myocardial infarction
$741,890Donald R. Menick · Medical University Of South Carolina · R01 · FY2024 · HL
Role of inflammation, innate resistance, and immunity in carcinogenesis
$741,872Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Epidemiologic Study of Brain Vitamin E, Diet & Age-Related Neurologic Diseases
$741,860Martha C. Morris · Rush University Medical Center · R01 · FY2009 · AG
Novel imaging agents of oxidative stress in the pathophysiology of the central nervous system
$741,829Kiel Neumann · University Of Virginia · R01 · FY2020 · EB
Ubiquitin-independent targeted protein degradation
$741,798Lizbeth K. Hedstrom · Brandeis University · R01 · FY2020 · GM
Novel coenzyme Q6 variant reveals non-immune determinants of survival during pneumococcal sepsis
$741,695Sharon Celeste Morley · Washington University · R01 · FY2025 · HL
Influence of T cell genotype/phenotype in atherosclerotic cardiovascular disease
$741,684Richard J Gumina · Ohio State University · R01 · FY2023 · HL
Informing optimal first-line antihypertensive therapy: A rigorous comparative effectiveness analysis of ARBs vs. ACEIs on long-term risk of dementia, cancer, heart disease, and quality of life
$741,675Jordana B. Cohen · University Of Pennsylvania · R01 · FY2025 · AG
Functional CT Assessment of Pulmonary Arterial Dysfunction in Smoking Associated Emphysema
$741,642Eric A Hoffman · University Of Iowa · R01 · FY2017 · HL
Quantitative Proteomics to Develop Robust Senescence-Related Biomarkers for Aging
$741,606Birgit Schilling · Buck Institute For Research On Aging · U01 · FY2021 · AG
Quantitative Proteomics to Develop Robust Senescence-Related Biomarkers for Aging
$741,606Birgit Schilling · Buck Institute For Research On Aging · U01 · FY2019 · AG
Quantitative Proteomics to Develop Robust Senescence-Related Biomarkers for Aging
$741,606Birgit Schilling · Buck Institute For Research On Aging · U01 · FY2022 · AG
Biomarkers for Muscle Function and Aging in Chronic HIV Infection
$741,597Monty A Montano · Brigham And Women'S Hospital · R01 · FY2015 · AI
Blood-Brain Barrier Disruption as a Biomarker for Perioperative Neurocognitive Disorder:Cognitive Recovery after Elective Surgery
$741,596Lori A Daiello · Rhode Island Hospital · R01 · FY2020 · AG
Blood-Brain Barrier Disruption as a Biomarker for Perioperative Neurocognitive Disorder:Cognitive Recovery after Elective Surgery
$741,596Lori A Daiello · Rhode Island Hospital · R01 · FY2021 · AG
Development of EP2 receptor antagonists for suppression of Alzheimer's neuropathology
$741,585Thota Ganesh · Emory University · U01 · FY2017 · AG